Trial intelligence / Profile preview

Phase I-II Study of Weekly CPT-11 and Radiation Therapy for Unresectable or Locally Recurrent Large Bowel Cancer

NCT00003344Phase 2Completed

Sponsor
Medical University of South Carolina
Start
Aug 1998
Primary completion
Jan 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by Medical University of South Carolina. Started Aug 1998; status: completed.

02

Drugs

irinotecan
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00003344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call